Form4insider filings, from the source

SEC Form 4 · accession 0001127602-17-009397

LEXICON PHARMACEUTICALS, INC. · LXRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Jeffrey L Wade
Officer — EVP, Corp Adm Affairs and CFO
Period of report
Feb 28, 2017
Accepted (ET)
Mar 1, 2017 · 6:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001062822

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Feb 28, 2017M2,429—A41,822D
Common StockF1Feb 28, 2017M2,928—A44,750D
Common StockF1Feb 28, 2017M5,807—A50,557D
Common StockF1Feb 28, 2017M4,495—A55,052D
Common StockFeb 28, 2017F6,455$16.45D48,597D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock Units (Phantom Stock)F1,F3—Feb 28, 2017M2,429D——Common Stock2,4290D
Restricted Stock Units (Phantom Stock)F1,F4—Feb 28, 2017M2,928D——Common Stock2,9282,929D
Restricted Stock Units (Phantom Stock)F1,F5—Feb 28, 2017M5,807D——Common Stock5,80711,614D
Restricted Stock Units (Phantom Stock)F1,F6—Feb 28, 2017M4,495D——Common Stock4,49513,485D

Explanation of responses